Donafenib in Progressive Locally Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Results of a Randomized, Multicenter, Phase II Trial.
Thyroid（2020）
Key words
donafenib,multikinase inhibitor,locally advanced or metastatic,radioactive iodine-refractory differentiated thyroid cancer,phase II trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined